Search research articles
Contact Us
Filters
Showing results (461-470 of 480) with videos related to
Page
of 48
Sort By:
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
December 1, 1982
[The effect of corticosteroids on experimental respiratory distress syndrome using oleic acid]
S L Liao, L Y Liu, S J Yang, et al.
Zhonghua Fu Chan Ke Za Zhi
|
November 25, 2021
[Comparative analysis of high risk factors between early-onset pre-eclampsia and late-onset pre-eclampsia]
X Lyu, W Y Zhang, J X Zhang, et al.
Journal of Medical Genetics
|
March 31, 2006
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome
C-W Lu, J-H Lin, Y S Rajawat, et al.
Zhonghua Fu Chan Ke Za Zhi
|
June 26, 2023
[Regional analysis of high risk factors of hypertensive disorders in pregnancy with organ or system impairment]
X Lyu, W Y Zhang, J X Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2000
Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library
T A Rano, Y Cheng, T T Huening, et al.
Current Drug Metabolism
|
July 24, 2001
Enzyme kinetics of cytochrome P450-mediated reactions
M Shou, Y Lin, P Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 19, 2000
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine
S K Balani, X Xu, B H Arison, et al.
Journal of Medical Virology
|
August 6, 2025
Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 Infection
Luis J Ponce, Yuqian Wang, Ananya Singh, et al.
Trials
|
June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.
Nature Medicine
|
November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
D DeFeo-Jones, V M Garsky, B K Wong, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 480) with videos related to
Sort By:
Page
of 48
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
December 1, 1982
[The effect of corticosteroids on experimental respiratory distress syndrome using oleic acid]
S L Liao, L Y Liu, S J Yang, et al.
Zhonghua Fu Chan Ke Za Zhi
|
November 25, 2021
[Comparative analysis of high risk factors between early-onset pre-eclampsia and late-onset pre-eclampsia]
X Lyu, W Y Zhang, J X Zhang, et al.
Journal of Medical Genetics
|
March 31, 2006
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome
C-W Lu, J-H Lin, Y S Rajawat, et al.
Zhonghua Fu Chan Ke Za Zhi
|
June 26, 2023
[Regional analysis of high risk factors of hypertensive disorders in pregnancy with organ or system impairment]
X Lyu, W Y Zhang, J X Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2000
Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library
T A Rano, Y Cheng, T T Huening, et al.
Current Drug Metabolism
|
July 24, 2001
Enzyme kinetics of cytochrome P450-mediated reactions
M Shou, Y Lin, P Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 19, 2000
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine
S K Balani, X Xu, B H Arison, et al.
Journal of Medical Virology
|
August 6, 2025
Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 Infection
Luis J Ponce, Yuqian Wang, Ananya Singh, et al.
Trials
|
June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.
Nature Medicine
|
November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
D DeFeo-Jones, V M Garsky, B K Wong, et al.
Page
of 48